MedTrace Logo

Parkinson's KinetiGraph, PKG in Patients With Deep Brain Stimulation and Continuous Levodopa Infusion Therapy

NCT02701803 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2019-06-27

No results posted yet for this study

Summary

In this study the aim is to evaluate the outcome of deep brain stimulation (DBS) and continuous intraduodenal levodopa therapy in patients with advanced Parkinson' disease by using Parkinson's KinetiGraph™ device which is a movement and acceleration measuring device. In this study we also evaluate the usability of Parkinson's KinetiGraph™ device by comparing it with written patient diaries.

Conditions

Interventions

DEVICE

Parkinson's KinetiGraph™ logger

Logger is recording device which records the movement and acceleration of upper extremity

Sponsors & Collaborators

  • Hospital District of Helsinki and Uusimaa

    lead OTHER

Principal Investigators

  • Eero Pekkonen, M.D., Ph.D. · HUH, Meilahti Hospital, department of neurology

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2017-12-31
Completion
2018-06-30

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02701803 on ClinicalTrials.gov